www.fdanews.com/articles/114832-shire-acquires-rights-to-adhd-drug
Shire Acquires Rights to ADHD Drug
February 20, 2009
Pharmaceutical firm Shire has signed an agreement with UCB to acquire the worldwide rights to EQUASYM IR and XL, used for the treatment of attention deficit hyperactivity (ADHD).
ShareCast
ShareCast